Perspectum, Europe’s fastest-growing life science company, has joined forces with ProPath, a local provider of pathology services.
The partnership will allow pharmaceutical companies to receive pathology and imaging expertise from one contact research organization when running clinical trials. Perspectum provides imaging technologies for monitoring and trial endpoints, improving decision making. Trials will have streamlined clinical data management and access to biopsy and imaging data with cloud-based storage.
“We are excited to start this partnership with ProPath, which will enable us to expand Perspectum’s efforts to streamline and improve decision-making in liver disease clinical trials. This combined offering will provide our customers with access to best-in-class pathology and imaging, in an integrated workflow. This collaboration also builds on Perspectum’s work developing digital pathology solutions, and we look forward to seeing these developments improve the landscape of clinical trials in liver, metabolic disease, and beyond,” says Dr Cathy O’Hare, Head of US Operations at Perspectum via release.
“Perspectum Diagnostics shares our commitment to best in class quality built on a foundation of patient focus. We feel that Perspectum represents the perfect partner for us. Together, we can provide a single, best quality location for contract research services. This will make it easy for investigators and companies to get all of their needs met and expectations exceeded in one place, faster and better than ever before,” says Dr. Cory Roberts, President, Chairman, and CEO at ProPath via release.
